6 completed, 1 withdrawn. 5 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Digoxin tablet: new trials by email Literature Review of Digoxin tablet trials Research Report on Digoxin tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects Exendin-4 Fc fusion protein (JY09) injection, Metformin Hydrochloride tablet, Rosuvastatin calcium tablets - Diabetes Mellitus, Type 2, Overweight | Phase 1 | Completed | Beijing Dongfang Biotech Co., Ltd. | 28 | 2023-10-19 | 2024-08-21 |
| Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma Digoxin tablet - Non-Medullary Thyroid Carcinoma | Not applicable | Completed | Radboud University Medical Center | 8 | 2022-12-06 | 2024-04-11 |
| A Study to Evaluate the Drug-drug Interactions (DDIs) of DBPR108 With Warfarin Sodium, Digoxin, Probenecid in Healthy Subjects Warfarin sodium tablets, Digoxin tablet, Probenecid tablets - Healthy Subjects | Phase 1 | Completed | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 28 | 2021-10-20 | 2022-03-10 |
| Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH) Digoxin tablet, Placebo - Nonalcoholic Steatohepatitis | Phase 2 | Withdrawn | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2020-06-01 | 2023-02-22 | |
| A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Transporter Pgp Substrate Digoxin in Advanced Solid Tumor Subjects Apatinib Mesylate, Digoxin tablet - Advanced Solid Tumor | Phase 1 | Completed | Jiangsu HengRui Medicine Co., Ltd. | 18 | 2020-03-12 | 2022-11-07 |
| A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone Omaveloxolone, Midazolam oral solution, Repaglinide 1 MG - Healthy Adult Subjects | Phase 1 | Completed | Biogen | 61 | 2019-06-14 | 2025-05-30 |
| Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers Tipranavir capsule, Tipranavir solution, Ritonavir capsule - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 34 | 2006-01-01 | 2014-09-18 |
Diabetes Mellitus, Type 2 (1) · Non-alcoholic Fatty Liver Disease (1) · Overweight (1) · Thyroid Cancer, Papillary (1) · Thyroid Neoplasms (1)
Beijing Dongfang Biotech Co., Ltd. (1) · Biogen (1) · Boehringer Ingelheim (1) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Radboud University Medical Center (1) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)
China (4) · Netherlands (1) · United States (1)
Jennifer Zon, MD (1)